Literature DB >> 21579827

4,6-Dichloro-5-methoxy-pyrimidine.

Hoong-Kun Fun, Chin Sing Yeap, C S Chidan Kumar, H S Yathirajan, M S Siddegowda.   

Abstract

The mol-ecule of the title compound, C(5)H(4)Cl(2)N(2)O, is close to being planar (r.m.s. deviation = 0.013 Å), apart from the C atom of the meth-oxy group, which deviates by 1.082 (2) Å from the mean plane of the other atoms. In the crystal, short Cl⋯N contacts [3.0940 (15) and 3.1006 (17) Å] generate a three-dimensional framework.

Entities:  

Year:  2010        PMID: 21579827      PMCID: PMC2979864          DOI: 10.1107/S1600536810001637

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For background to the importance of pyrimidines and analogous compounds in pharmaceutical and biological fields, see: Townsend & Drach (2002a ▶,b ▶). For related structures, see: Bukhari et al. (2008 ▶, 2009 ▶); Fun et al. (2006 ▶, 2008 ▶)); Yathirajan et al. (2007 ▶); Zhao et al. (2009 ▶). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C5H4Cl2N2O M = 179.00 Orthorhombic, a = 13.6545 (19) Å b = 3.9290 (6) Å c = 13.0275 (18) Å V = 698.91 (17) Å3 Z = 4 Mo Kα radiation μ = 0.85 mm−1 T = 100 K 0.29 × 0.20 × 0.09 mm

Data collection

Bruker APEX Duo CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.787, T max = 0.926 4505 measured reflections 1520 independent reflections 1415 reflections with I > 2σ(I) R int = 0.024

Refinement

R[F 2 > 2σ(F 2)] = 0.024 wR(F 2) = 0.054 S = 1.08 1520 reflections 92 parameters 1 restraint H-atom parameters constrained Δρmax = 0.27 e Å−3 Δρmin = −0.19 e Å−3 Absolute structure: Flack (1983 ▶), 459 Friedel pairs Flack parameter: −0.02 (6) Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810001637/hb5305sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810001637/hb5305Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C5H4Cl2N2OF(000) = 360
Mr = 179.00Dx = 1.701 Mg m3
Orthorhombic, Pna21Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2c -2nCell parameters from 1997 reflections
a = 13.6545 (19) Åθ = 3.0–32.2°
b = 3.9290 (6) ŵ = 0.85 mm1
c = 13.0275 (18) ÅT = 100 K
V = 698.91 (17) Å3Block, colourless
Z = 40.29 × 0.20 × 0.09 mm
Bruker APEX Duo CCD diffractometer1520 independent reflections
Radiation source: fine-focus sealed tube1415 reflections with I > 2σ(I)
graphiteRint = 0.024
φ and ω scansθmax = 30.0°, θmin = 3.0°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −19→17
Tmin = 0.787, Tmax = 0.926k = −5→4
4505 measured reflectionsl = −18→13
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.024H-atom parameters constrained
wR(F2) = 0.054w = 1/[σ2(Fo2) + (0.0274P)2 + 0.0046P] where P = (Fo2 + 2Fc2)/3
S = 1.08(Δ/σ)max = 0.001
1520 reflectionsΔρmax = 0.27 e Å3
92 parametersΔρmin = −0.19 e Å3
1 restraintAbsolute structure: Flack (1983), 459 Friedel pairs
Primary atom site location: structure-invariant direct methodsFlack parameter: −0.02 (6)
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl11.00227 (3)0.39313 (10)0.31491 (4)0.01880 (10)
Cl20.68657 (3)−0.13063 (10)0.50590 (3)0.01823 (10)
O10.87265 (8)0.2620 (3)0.49779 (10)0.0158 (2)
N10.85636 (12)0.0895 (4)0.22384 (12)0.0173 (3)
N20.71682 (10)−0.1454 (3)0.30807 (13)0.0164 (3)
C10.89051 (11)0.1878 (4)0.31413 (16)0.0146 (3)
C20.77002 (14)−0.0714 (5)0.22517 (14)0.0176 (4)
H2A0.7446−0.13820.16210.021*
C30.75310 (13)−0.0416 (4)0.39696 (13)0.0134 (3)
C40.84177 (14)0.1346 (4)0.40704 (14)0.0136 (3)
C50.94496 (15)0.0608 (5)0.55200 (16)0.0225 (4)
H5A0.9966−0.00130.50570.034*
H5B0.9147−0.14130.57860.034*
H5C0.97150.19170.60770.034*
U11U22U33U12U13U23
Cl10.01301 (17)0.02330 (19)0.02010 (18)−0.00290 (14)0.00081 (16)0.0021 (2)
Cl20.01565 (17)0.02443 (19)0.01463 (17)−0.00177 (15)0.00211 (17)0.00248 (19)
O10.0159 (5)0.0185 (5)0.0130 (5)0.0029 (4)−0.0029 (6)−0.0044 (6)
N10.0148 (7)0.0222 (8)0.0150 (7)0.0019 (6)−0.0012 (6)−0.0009 (6)
N20.0152 (6)0.0182 (7)0.0159 (7)0.0014 (5)−0.0030 (7)−0.0010 (6)
C10.0114 (6)0.0150 (7)0.0174 (7)0.0020 (5)0.0012 (8)0.0010 (7)
C20.0172 (9)0.0213 (10)0.0145 (8)0.0015 (7)−0.0028 (7)−0.0019 (7)
C30.0127 (8)0.0144 (8)0.0130 (7)0.0017 (6)0.0005 (7)0.0016 (6)
C40.0133 (8)0.0133 (7)0.0142 (8)0.0030 (5)−0.0015 (6)−0.0003 (6)
C50.0261 (10)0.0243 (9)0.0170 (8)0.0052 (7)−0.0097 (8)−0.0013 (8)
Cl1—C11.7262 (16)N2—C21.334 (2)
Cl2—C31.7210 (19)C1—C41.397 (3)
O1—C41.351 (2)C2—H2A0.9300
O1—C51.449 (2)C3—C41.401 (3)
N1—C11.323 (2)C5—H5A0.9600
N1—C21.338 (2)C5—H5B0.9600
N2—C31.324 (2)C5—H5C0.9600
C4—O1—C5115.92 (13)C4—C3—Cl2118.65 (14)
C1—N1—C2115.91 (16)O1—C4—C1123.64 (16)
C3—N2—C2115.93 (14)O1—C4—C3122.32 (16)
N1—C1—C4123.97 (15)C1—C4—C3113.86 (16)
N1—C1—Cl1116.95 (14)O1—C5—H5A109.5
C4—C1—Cl1119.08 (14)O1—C5—H5B109.5
N2—C2—N1126.41 (17)H5A—C5—H5B109.5
N2—C2—H2A116.8O1—C5—H5C109.5
N1—C2—H2A116.8H5A—C5—H5C109.5
N2—C3—C4123.89 (16)H5B—C5—H5C109.5
N2—C3—Cl2117.46 (14)
C2—N1—C1—C4−0.4 (2)N1—C1—C4—O1−173.85 (16)
C2—N1—C1—Cl1179.51 (12)Cl1—C1—C4—O16.2 (2)
C3—N2—C2—N11.5 (2)N1—C1—C4—C31.4 (2)
C1—N1—C2—N2−1.1 (3)Cl1—C1—C4—C3−178.53 (12)
C2—N2—C3—C4−0.3 (2)N2—C3—C4—O1174.29 (15)
C2—N2—C3—Cl2179.80 (13)Cl2—C3—C4—O1−5.8 (2)
C5—O1—C4—C1−85.2 (2)N2—C3—C4—C1−1.0 (2)
C5—O1—C4—C399.96 (19)Cl2—C3—C4—C1178.89 (12)
  6 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  A second monoclinic polymorph of 2-amino-4,6-dichloro-pyrimidine.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; Subrata Jana; Rinku Chakrabarty; Shyamaprosad Goswami
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-08-06

3.  4-(4-Chloro-phen-yl)-6-(methyl-sulfan-yl)pyrimidin-2-amine.

Authors:  Qi-Hua Zhao; Li-Nan Li; Kun-Miao Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-08

4.  4-(4-Fluoro-phen-yl)-6-(2-fur-yl)pyrimidin-2-amine.

Authors:  Mujahid Hussain Bukhari; Hamid Latif Siddiqui; Muhammad Ashraf Chaudhary; Tanvir Hussain; Masood Parvez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-05-03

5.  4-(4-Bromo-phen-yl)-6-(4-chloro-phen-yl)-pyrimidin-2-ylamine.

Authors:  Mujahid Hussain Bukhari; Hamid Latif Siddiqui; Naveed Ahmad; Waseeq Ahmad Siddiqui; Masood Parvez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-28

6.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.